The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
The journey from designing cell and gene therapies for research studies to manufacturing them in a cGMP environment and making them available to patients is costly, time-sensitive, and filled with numerous challenges. By partnering with an industry-leading CDMO that follows a “begin-with-the-end-in-mind” approach for translational research projects, you can reduce risk, accelerate development, and seamlessly transition to cGMP manufacturing, ultimately helping patients access life-changing therapies, faster. Download our fact sheet to learn more.